For example, FABP1 enhances mitochondrial β-oxidation in hepatocellular carcinoma to provide energy[18], while FABP4 promotes breast cancer cells to take up fatty acids from adipocytes and activates the STAT3 pathway to drive epithelial-mesenchymal transition (EMT)[70]. Here, FABP4 is linked to breast carcinoma.